Related Experiment Video
Updated: Nov 11, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Pure extra-thoracic sarcoidosis: about 24 cases
Donia Chebbi1, Sameh Marzouk1, Mouna Snoussi1
1Department of Internal Medicine, Hedi Chaker University Hospital, Sfax, Tunisia.
Pure extra-thoracic sarcoidosis is rare, with this study highlighting its diverse systemic manifestations in a Tunisian population. This form presented fewer lymphadenopathies and less frequent corticosteroid use compared to intra-thoracic sarcoidosis.
Area of Science:
- Internal Medicine
- Rheumatology
- Pulmonology
Background:
- Pure extra-thoracic sarcoidosis is an uncommon clinical presentation.
- Limited literature characterizes the features of sarcoidosis without intrathoracic involvement.
- Understanding extra-thoracic sarcoidosis is crucial for comprehensive patient management.
Purpose of the Study:
- To describe the clinical features of pure extra-thoracic sarcoidosis.
- To compare these features with sarcoidosis involving the thorax.
- To identify associations between clinical manifestations in extra-thoracic sarcoidosis.
Main Methods:
- Retrospective, descriptive, and comparative study.
- Involved 24 patients with pure extra-thoracic sarcoidosis over 21 years (1996-2016).
- Data collected from the Department of Internal Medicine, Hedi Chaker University Hospital, Sfax, Tunisia.
Main Results:
- Pure extra-thoracic sarcoidosis constituted 30% of systemic cases, with female predominance (79%) and mean age of 50.
- Common manifestations included polyadenopathies (41.7%), cutaneous involvement (41.6%), and inflammatory polyarthralgia (33.3%).
- Compared to intra-thoracic sarcoidosis, pure extra-thoracic form showed less lymphadenopathy (p=0.001) and lower corticosteroid use (p=0.044).
Conclusions:
- The study highlights the frequency of the pure extra-thoracic sarcoidosis form in this population.
- Diverse systemic manifestations characterize pure extra-thoracic sarcoidosis.
- Further research is needed to fully elucidate the pathophysiology and optimal treatment of this rare sarcoidosis variant.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pericarditis II: Clinical Features and Diagnostic Tests
Case Studies

